RIGEL PHARMACEUTICALS, INC. (RIGL) Shareholders’ equity 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) shareholders’ equity at each fiscal year-end, per SEC filings.
$391.5MFY2025 · since FY2016: $55.0M → $391.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $391.5M | +11806.3% |
| FY2024 | $3.3M | +111.5% |
| FY2023 | -$28.6M | -110.4% |
| FY2022 | -$13.6M | -144.8% |
| FY2021 | $30.4M | -10.7% |
| FY2020 | $34.0M | -36.8% |
| FY2019 | $53.8M | -51.0% |
| FY2018 | $109.9M | +9.2% |
| FY2017 | $100.6M | +82.9% |
| FY2016 | $55.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice